Location History:
- Ushiku, JP (2006)
- Tsukuba, JP (2010 - 2012)
- Ibaraki, JP (2003 - 2015)
- Moriya, JP (2017)
Company Filing History:
5 out of 677 
4 out of 529 
1 out of 832,880 Years Active: 2003-2017
Title: Innovations of Tatsuo Horizoe
Introduction
Tatsuo Horizoe is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of nine patents to his name, Horizoe's work has the potential to impact the treatment of various diseases.
Latest Patents
One of Horizoe's latest patents is focused on neutralizing anti-CCL20 antibodies. This invention relates to novel humanized, chimeric, and murine antibodies that specifically bind to the human CC chemokine ligand 20 (CCL20). The patent also covers the heavy and light chains of these antibodies, as well as isolated nucleic acids, recombinant vectors, and host cells that encode these chains. The anti-CCL20 antibodies developed through this invention can be utilized in therapeutic applications to treat inflammatory and autoimmune disorders, as well as cancer.
Another patent by Horizoe also pertains to nucleic acids encoding neutralizing anti-CCL20 antibodies. Similar to the previous patent, it involves the development of antibodies with binding specificity for CCL20 and includes methods for preparing these antibodies. The therapeutic applications of these antibodies further emphasize their importance in medical research and treatment.
Career Highlights
Throughout his career, Tatsuo Horizoe has worked with notable companies in the pharmaceutical industry, including Eisai Company, Limited and Eisai R&D Management Co., Ltd. His experience in these organizations has contributed to his expertise in the field of antibody development and therapeutic innovations.
Collaborations
Horizoe has collaborated with esteemed colleagues such as Osamu Asano and Hitoshi Harada. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of innovative therapeutic solutions.
Conclusion
Tatsuo Horizoe's contributions to the field of biotechnology, particularly through his patents on anti-CCL20 antibodies, showcase his dedication to advancing medical science. His work has the potential to significantly improve treatment options for various diseases, highlighting the importance of innovation in healthcare.